Control of hypothalamic-pituitary-adrenal stress axis activity by the intermediate conductance calcium-activated potassium channel, SK4

Journal of Physiology

Volumn 589, Issue 24, 2011, Pages 5965-5986

  Liang, Zhi ^a   Chen, Lie ^a   Mcclafferty, Heather ^a   Lukowski, Robert ^b   Macgregor, Duncan ^a   King, Jonathan T ^c   Rizzi, Sandra ^d   Sausbier, Matthias ^b   Mccobb, David P ^c   Knaus, Hans Guenther ^d   Ruth, Peter ^b   Shipston, Michael J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Department of Molecular Biology and Genetics   (United States)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL SK4; MESSENGER RNA; NUCLEAR RECEPTOR NUR77; PROTEIN C FOS; UNCLASSIFIED DRUG;

ACTH SECRETING CELL; ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DEPOLARIZATION; EXCITABILITY; FEMALE; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE STEADY POTENTIAL; MOUSE; NONHUMAN; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM CONDUCTANCE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELLS, CULTURED; FEMALE; HEK293 CELLS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; LENTIVIRUS; MEMBRANE POTENTIALS; MICE; MICE, KNOCKOUT; PITUITARY-ADRENAL SYSTEM; RESTRAINT, PHYSICAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; TRANSDUCTION, GENETIC;

EID: 83455220287     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.219378     Document Type: Article

References (45)

1. Antoni FA (1986). Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 7, 351-378.
2. 2+ buffers. Methods Cell Biol 40, 3-29.
3. Brunton PJ, Sausbier M, Wietzorrek G, Sausbier U, Knaus H-G, Russell JA, Ruth P & Shipston MJ (2007). Hypothalamic-pituitary-adrenal axis hyporesponsiveness to restraint stress in mice deficient for large-conductance calcium- and voltage-activated potassium (BK) channels. Endocrinology 148, 5496-5506.
4. Budry L, Lafont C, el Yandouzi T, Chauvet N, Conejero G, Drouin J & Mollard P (2011) Related pituitary cell lineages develop into interdigitted 3D cell networks. Proc Natl Acad Sci U S A 108, 12515-12520
5. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J & Wittwer CT (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55, 611-622.
6. Chan RKW, Brown ER, Ericsson A, Kovacs KJ & Sawchenko PE (1993). A comparison of 2 immediate-early genes, C-Fos and Ngfi-B, as markers for functional activation in stress-related neuroendocrine circuitry. J Neurosci 13, 5126-5138.
7. Childs GV, Marchetti C & Brown AM (1987). Involvement of sodium channels and two types of calcium channels in the regulation of adrenocorticotropin release. Endocrinology 120, 2059-2069.
8. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L & Levin N (1987). Regulation of ACTH secretion: variations on a theme of B. Rec Prog Hormo Res 43, 113-173.
9. Gerlach AC, Gangopadhyay NN & Devor DC (2000). Kinase-dependent regulation of the intermediate conductance, calcium-dependent potassium channel, hIK1. J Biol Chem 275, 585-598.
10. Gibbs DM & Vale W (1982). Presence of corticotropin releasing factor-like immunoreactivity in hypophysial portal blood. Endocrinology 111, 1418-1420.
11. Hammer GD, Fairchild-Huntress V & Low MJ (1990). Pituitary-specific and hormonally regulated gene expression directed by the rat proopiomelanocortin promoter in transgenic mice. Mol Endocrinol 4, 1689-1697.
12. Hodgkinson SC, Allolio B, Landon J & Lowry PJ (1984). Development of a non-extracted 2-site immunoradiometric assay for corticotropin utilizing extreme amino-terminally and carboxy-terminally directed antibodies. Biochem J 218, 703-711.
13. + channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration. J Neurosci 27, 234-244.
14. Keith LD, Winslow JR & Reynolds RW (1978). A general procedure for estimation of corticosteroid response in individual rats. Steroids 31, 523-531.
15. +-channel transgenic mice. Pflugers Arch 459, 969-976.
16. Kuryshev YA, Haak L, Childs GV & Ritchie AK (1997). Corticotropin releasing hormone inhibits an inwardly rectifying potassium current in rat corticotropes. J Physiol 502, 265-279.
17. LeBeau AP, Robson AB, McKinnon AE, Donald RA & Sneyd J (1997). Generation of action potentials in a mathematical model of corticotrophs. Biophys J 73, 1263-1275.
18. Lee AK, Smart JL, Rubinstein M, Low MJ & Tse A (2011). Reciprocal regulation of TREK-1 channels by arachidonic acid and CRH in mouse corticotropes. Endocrinology 152, 1901-1910.
19. 2+ rise in identified rat corticotrophs. J Physiol 504, 367-378.
20. -ΔΔCT method. Methods 25, 402-408.
21. McEwen BS & Wingfield JC (2003). The concept of allostasis in biology and biomedicine. Horm Behav 43, 2-15.
22. +, corticotropin-releasing factor, and angiotensin II. Endocrinology 121, 395-405.
23. Pacak K & Palkovits M (2001). Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders. Endocr Rev 22, 502-548.
24. Pennington AJ, Kelly JS & Antoni FA (1994). Selective enhancement of an A type potassium current by dexamethasone in a corticotroph cell line. J Neuroendocrinol 6, 305-315.
25. Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, Friedman JM & Horvath TL (2004). Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304, 110-115.
26. Ritchie AK, Kuryshev YA & Childs GV (1996). Corticotropin-releasing hormone and calcium signaling in corticotropes. Trends Endocrinol Metab 7, 365-369.
27. Sapolsky RM, Romero LM & Munck AU (2000). How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocr Rev 21, 55-89
28. + secretion occurs via BK channels. J Am Soc Nephrol 17, 1275-1282.
29. Schilling T & Eder C (2007). TRAM-34 inhibits nonselective cation channels. Pflugers Arch 454, 559-563.
30. Sheward WJ & Fink G (1991). Effects of corticosterone on the secretion of corticotrophin-releasing factor, arginine vasopressin and oxytocin into hypophysial portal blood in long-term hypophysectomized rats. J Endocrinol 129, 91-98.
31. Shipston MJ, Kelly JS & Antoni FA (1996). Glucocorticoids block protein kinase a inhibition of calcium-activated potassium channels. J Biol Chem 271, 9197-9200.
32. Shorten PR, Robson AB, McKinnon AE & Wall DJ (2000). CRH-induced electrical activity and calcium signalling in pituitary corticotrophs. J Theor Biol 206, 395-405.
33. Simasko SM (1994). A background sodium conductance is necessary for spontaneous depolarizations in rat pituitary cell line GH3. Am J Physiol Cell Physiol 266, C709-C719.
34. Stojilkovic SS, Tabak J & Bertram R (2010). Ion channels and signaling in the pituitary gland. Endocr Rev 31, 845-915.
35. Surprenant A (1982). Correlation between electrical activity and ACTH/β-endorphin secretion in mouse pituitary tumor cells. J Cell Biol 95, 559-566.
36. Tabak J, Toporikova N, Freeman ME & Bertram R (2007). Low dose of dopamine may stimulate prolactin secretion by increasing fast potassium currents. J Comput Neurosci 22, 211-222.
37. Takano K, Yasufuku-Takano J, Teramoto A & Fujita T (1996). Corticotropin-releasing hormone excites adrenocorticotropin-secreting human pituitary adenoma cells by activating a nonselective cation current. J Clin Invest 98, 2033-2041.
38. Tomic M, Kucka M, Kretshmannova K, Li S, Nesterova M, Stratakis CA & Stojilkovic SS (2011). Role of non-selective cation channels in spontaneous and protein kinase A stimulated calcium signalling in pituitary cells. Am J Physiol Endocrinol Metab 301, E370-379.
39. Tsaneva-Atanasova K, Sherman A, van Goor F & Stojilkovic SS (2007). Mechanism of spontaneous and receptor-controlled electrical activity in pituitary somatotrophs: experiments and theory. J Neurophysiol 98, 131-144.
40. Tse A & Lee AK (1998). Arginine vasopressin triggers intracellular calcium release, a calcium-activated potassium current and exocytosis in identified rat corticotropes. Endocrinology 139, 2246-2252.
41. Wojtulewski JA, Gow PJ, Walter J, Grahame R, Gibson T, Panayi GS & Mason J (1980). Clotrimazole in rheumatoid arthritis. Ann Rheum Dis 39, 469-472.
42. + current by clotrimazole in rat anterior pituitary GH3 cells. Neuropharmacology 38, 979-989.
43. Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier J-M & Shakkottai V (2007). Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem 14, 1437-1457.
44. + channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A 97, 8151-8156.
45. Yuan JS, Reed A, Chen F & Stewart CN (2006). Statistical analysis of real-time PCR data. BMC Bioinformatics 7, 85.